ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 81 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,088 | -16.3% | 10,369 | -0.8% | 0.00% | – |
Q2 2023 | $9,665 | -21.5% | 10,449 | -7.5% | 0.00% | – |
Q1 2023 | $12,315 | -16.1% | 11,298 | +12.4% | 0.00% | – |
Q4 2022 | $14,670 | +33.4% | 10,048 | -5.0% | 0.00% | – |
Q3 2022 | $11,000 | -38.9% | 10,573 | 0.0% | 0.00% | – |
Q2 2022 | $18,000 | -18.2% | 10,573 | 0.0% | 0.00% | – |
Q1 2022 | $22,000 | -78.8% | 10,573 | +1.7% | 0.00% | – |
Q2 2020 | $104,000 | +82.5% | 10,401 | -50.0% | 0.00% | – |
Q1 2020 | $57,000 | +62.9% | 20,801 | -29.3% | 0.00% | – |
Q4 2019 | $35,000 | -10.3% | 29,411 | +13.7% | 0.00% | – |
Q3 2019 | $39,000 | -56.2% | 25,865 | +16.9% | 0.00% | – |
Q2 2019 | $89,000 | -31.5% | 22,135 | -26.7% | 0.00% | – |
Q1 2019 | $130,000 | -1.5% | 30,185 | +31.8% | 0.00% | – |
Q4 2018 | $132,000 | -32.3% | 22,906 | +59.0% | 0.00% | – |
Q3 2018 | $195,000 | +5.4% | 14,408 | -7.6% | 0.00% | – |
Q2 2018 | $185,000 | -34.4% | 15,596 | -38.0% | 0.00% | -100.0% |
Q1 2018 | $282,000 | +147.4% | 25,140 | +47.2% | 0.00% | – |
Q4 2017 | $114,000 | – | 17,084 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Syncona Portfolio Ltd | 1,377,294 | $1,501,250 | 2.44% |
NEA Management Company, LLC | 17,079,779 | $18,616,958 | 1.29% |
Endurant Capital Management LP | 1,660,835 | $1,810,310 | 0.93% |
Matrix Capital Management Company, LP | 38,974,185 | $42,481,862 | 0.58% |
Long Focus Capital Management, LLC | 5,435,439 | $5,924,629 | 0.34% |
PFM Health Sciences, LP | 5,992,571 | $6,531,902 | 0.29% |
Key Client Fiduciary Advisors, LLC | 321,155 | $350,059 | 0.22% |
DAFNA Capital Management LLC | 351,064 | $382,660 | 0.12% |
Rock Springs Capital Management LP | 2,787,845 | $3,038,751 | 0.07% |
Baker Brothers Advisors | 9,830,877 | $10,715,656 | 0.06% |